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Leptospirosis has been overlooked in Africa and lack of 
awareness has been a major limitation in quantifying the 
burden of disease. Medical clinicians often lack 
awareness of leptospirosis as a differential diagnosis 
for malaria and other endemic acute febrile illnesses1 
and have limited access to laboratory facilities for 
diagnostic support. The lack of data on leptospirosis in 
many African countries2 means that local public and 
animal health ofcials and governments are unaware of 
this disease and its potential impact on both human and 
animal health, as well as consequent socio-economic 
and environmental impacts.
Leptospirosis research activities have remained 
fragmented with researchers from both Africa and 
elsewhere often working in isolation. There is very little 
disease-specic infrastructure or expertise in Africa 
and with little continuity at study sites, within countries 
or indeed within regions. However, several leptospirosis 
workers are involved in projects in the African 
countries3-5 and many people receive regular requests 
from students and professionals interested in working 
on leptospirosis in Africa. A clear need has been 
identied to bring together those involved with and 
concerned about the leptospirosis situation in Africa to 
address and overcome these challenges.
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Leptospirosis Researchers at Massey University, New 
Zealand and at the University of Glasgow, Scotland with 
Dr Rudy Hartskeerl from the WHO/FAO/OIE Leptospirosis 
Reference Laboratory in the Netherlands have 
established a network to foster communication and 
advance activities and initiatives around leptospirosis in 
the African continent. At November 29 2016 we have 47 
people in the network with approximately half located on 
the continent. Current network participants heighten 
awareness of this network and identify individuals and 
institutional and governmental agencies who would 
benet from membership.
Through our Alfresco Collaboration Platform:
• those with an interest in leptospirosis in Africa are 
identied, and can participate and share expertise
• existing, new and evolving evidence for the presence, 
epidemiology, management and burden of 
leptospirosis in African countries is disseminated and 
shared
• evidence about leptospirosis in humans, animals and 
the environment can be collated and used to raise 
awareness of this disease in African countries and 
internationally
•  capacity building in areas of disease recognition, 
epidemiology, and management in people, animals 
and the environment can be encouraged
• protocols can be made available (e.g. laboratory 
SOPs, rodent trapping and abattoir  sampling)
• funding sources can be identified and pursued
Background
Why build a network?
A keynote presentation on ‘Leptospirosis: commonly 
forgotten in Africa’ (Georgies Mgode, Sokoine 
University of Agriculture, Tanzania) led to an informal 
meeting of leptospirologists interested in assisting the 
development of awareness and understanding of 
leptospirosis in Africa at the European Leptospirosis 
Society Meeting (April 2015, The Netherlands).  
Subsequently, a second, larger meeting was held in 
association with the International Leptospirosis Society 
meeting (October 2015, Indonesia) to further develop 
plans to establish a formal network of those involved in, 
or interested in being involved in, researching 
leptospirosis in Africa.  And this was endorsed at the 
Global Leptospirosis Environmental Action Network 
(GLEAN, WHO) meeting (November 2015, Brazil).  
Growing interest in lepto in Africa
What are we doing?
Geographic distribution of acute human leptospirosis and
conrmed animal Leptospira spp. infection in Africa. 
Adapted from Allan et al. (2015) PLoS NTD 9(9) e0003899.
Future plans
We aim to identify which of the following are useful 
recommendations or interventions for addressing 
human leptospirosis in diverse settings in Africa:
• Assessment of the performance of currently 
available rapid tests in multiple settings to help with 
case detection.
• A diagnostic algorithm that could be used in the 
absence of a laboratory test.
• Clinical guidelines for managing patients with severe 
leptospirosis (either from a confirmed or suspected 
diagnosis).
• An evidence-based chemoprophylaxis protocol.
• Support for identification of infecting serovar.
• Securing scholarships for attendance at the 
International Leptospirosis Society meeting and 
workshops in New Zealand in 2017.
• Holding an African Leptospirosis Network meeting in 
2018 in Africa.
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